(MENAFN- Newsfile Corp) Vancouver, British Columbia--(Newsfile Corp. - October 22, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the " Company " or " FendX "), an innovative surface protection company developing their technology-based solutions to reduce the spread of harmful pathogens and support a cleaner, safer world, is pleased to announce the filing of a provisional patent application with the United States Patent and Trademark Office. The application, titled "Antimicrobial Coating for Long-Lasting Pathogen Control on High-Touch Surfaces", assigned application number 63/936,328, was filed on August 7, 2025, by Drs. Carolyn Myers, Tohid Didar, Leyla Soleymani and Sara Moetakef Imani, with FendX as the assignee. This filing marks a significant addition to the Company's expanding portfolio of hygiene-related technologies.

The new application describes a novel nanoparticle liquid coating (formerly described as the spray technology) designed to provide long-lasting protection against a broad spectrum of pathogens found on high-touch surfaces. Engineered for easy application, using for example, a roller or brush, the coating leverages nanoparticle technology to actively disrupt microbial contamination, offering sustained efficacy in multiple settings.

"We are pleased with the progress of our development efforts on this liquid coating technology which have resulted in the filing of this patent application," said Dr. Carolyn Myers, CEO of FendX. "We are now actively assessing scale-up and distribution partnership opportunities to bring this technology to the market. This innovation underscores FendX's commitment to developing scalable solutions aimed at reducing infection risk . "

About FendX Technologies Inc.

FendX is a surface protection company leveraging its proprietary technology to develop product solutions that help reduce the spread of harmful pathogens in everyday environments. The Company is advancing its pipeline of products under development which includes REPELWRAPTM film, a protective surface coating with repelling properties that significantly reduce adhesion and transmission of pathogens on high-touch surfaces, and nanoparticle infused liquid coating with similar functionality. Additionally, the Company is developing specialized catheter coatings, with its first coating being for Foley catheters. The Company holds exclusive worldwide licenses and intellectual property for its coating technologies.

ON BEHALF OF THE COMPANY

"Carolyn Myers"
Carolyn Myers
Chief Executive Officer and Director

MENAFN22102025004218003983ID1110231168